Tag: NGS based RNA sequencing market forecast

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

NGS-Based RNA-Sequencing Market Size, Value And Growth Trajectory Through 2030

The ngs-based rna-sequencing market has experienced significant expansion in recent years. It is anticipated to grow from $4.2 billion in 2025 to $5.27 billion in 2026, achieving a compound annual growth rate (CAGR) of 25.3%. Historically, this growth has been driven by the expansion of genomic research initiatives, declining cost of sequencing technologies, increased use of rna-seq in academic research, availability of advanced sequencing platforms, and the growth of bioinformatics capabilities.

The ngs-based rna-sequencing market size is anticipated to experience significant growth in the coming years. It is projected to expand to $12.73 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 24.7%. This projected growth throughout the forecast period stems from factors such as the increasing adoption of rna sequencing in clinical diagnostics, rising investments in precision medicine, the expansion of pharmaceutical research applications, a growing demand for integrated data analysis solutions, and an increasing focus on multi-omics research. Major trends influencing this period include the rising adoption of high-throughput rna sequencing platforms, an increasing demand for single-cell rna sequencing, the growing utilization of cloud-based bioinformatics analysis, the expansion of transcriptomics in precision medicine, and an enhanced focus on data accuracy and scalability.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=94241890&type=smp&name=NGS-Based%20RNA-Sequencing%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

NGS-Based RNA-Sequencing Market Development Factors: What’s Supporting Demand?

The expanding pharmaceutical sector is anticipated to fuel the growth of the NGS-based RNA-sequencing market in the future. This industry encompasses the entire process of discovering, developing, and manufacturing drugs and medications, undertaken by both government and private organizations. NGS-based RNA-sequencing is employed by the pharmaceutical industry for in-depth analysis of gene expression, pinpointing potential drug targets, evaluating how drugs interact, and unraveling disease mechanisms. This advanced technique enhances drug discovery and development by providing a profound insight into molecular processes. For instance, data from June 2025, as reported by the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, showed that prescription drug outlays increased by 11.4% in 2023, reaching $449.7 billion, which was an acceleration from the 7.8% growth recorded in 2022. Consequently, the expansion of the pharmaceutical industry is a significant impetus behind the growth of the NGS-based RNA-sequencing market.

NGS-Based RNA-Sequencing Market Segmentation And Category Overview

The ngs-based rna-sequencing market covered in this report is segmented –

1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management

2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing

3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly

4) By End User: Research & Academia, Pharmaceutical & Biotechnology Companies, Other End Users

Subsegments:

1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents

2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables

3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services

4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms

NGS-Based RNA-Sequencing Market Transformation Trends: What Innovations Are Driving Change?

Leading companies within the NGS-based RNA-sequencing market are prioritizing the creation of innovative products, such as advanced small RNA-seq kits, to optimize processes and enhance the precision and effectiveness of RNA expression analysis. These cutting-edge library preparation solutions are engineered to precisely isolate and sequence minute RNA molecules with high accuracy. They assist researchers in expediting research procedures, mitigating unwanted byproducts like adapter dimers, and obtaining more dependable and consistent expression profiles. For Instance, in October 2025, Lexogen, an Austria-based biotechnology company, launched the miRVEL Profiling Small RNA-Seq Library Prep Kit, specifically designed to streamline and enhance small RNA research workflows. This groundbreaking kit offers an expedited and dependable process, enabling the preparation of sequencing-ready libraries in under seven hours with minimal hands-on effort. It incorporates sophisticated adapter blocking mechanisms to avert the creation of adapter dimers, guarantees consistent outcomes irrespective of input quantity, and includes built-in 8 nt unique dual indices (UDIs) for accurate multiplexing and read assignment. The miRVEL Profiling Kit caters to diverse research applications, including RNA interference studies, host-defense mechanism investigations, and plant or agricultural small RNA research. Additionally, it integrates seamlessly with Lexogen’s SPLIT RNA extraction kits and TraPR small RNA enrichment system, offering a comprehensive, complete solution for small RNA analysis.

NGS-Based RNA-Sequencing Market Competitive Overview And Top Companies

Major companies operating in the ngs-based rna-sequencing market are Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Genohub LLC, BaseClear B.V., Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

View The Full NGS-Based RNA-Sequencing Market Report:

https://thebusinessresearchcompany.com/report/NGS-based-RNA-sequencing-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

NGS-Based RNA-Sequencing Market Leading Geography: Which Region Contributes The Most Revenue?

North America was the largest region in the NGS-based RNA sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

By 2030, How Much Growth In Market Size Is Expected For The NGS-Based RNA-Sequencing Market?

The ngs-based rna-sequencing market size has experienced significant expansion in recent years. It is anticipated to increase from $4.2 billion in 2025 to $5.27 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 25.3%. The growth observed in prior periods can be attributed to the broadening of genomic research initiatives, a reduction in the cost of sequencing technologies, expanded utilization of rna-seq in academic research, the accessibility of advanced sequencing platforms, and the development of bioinformatics capabilities.

The ngs-based rna-sequencing market is projected for rapid expansion in the coming years. This market is anticipated to reach a valuation of $12.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 24.7%. Drivers for this growth during the projected timeframe include the expanding use of RNA sequencing in clinical diagnostics, increased funding for precision medicine, the broadening scope of pharmaceutical research applications, a rising need for integrated data analysis tools, and a heightened emphasis on multi-omics research. Key trends expected within this period involve the greater uptake of high-throughput RNA sequencing platforms, increasing interest in single-cell RNA sequencing, wider utilization of cloud-based bioinformatics analysis, the integration of transcriptomics into precision medicine, and a stronger focus on data precision and scalability.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp

What Key Growth Drivers Are Influencing The NGS-Based RNA-Sequencing Market?

The expanding pharmaceutical sector is anticipated to boost the future growth of the NGS-based RNA-sequencing market. This industry encompasses the discovery, development, and production of drugs and medicines by both governmental and private entities. The pharmaceutical industry utilizes NGS-based RNA-sequencing for comprehensive analysis of gene expression, identification of potential drug targets, assessment of drug responses, and understanding disease mechanisms, thereby facilitating drug discovery and development through a deeper understanding of molecular processes. For instance, in June 2025, according to the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, prescription drug outlays increased by 11.4% in 2023, reaching $449.7 billion, which was an acceleration from the 7.8% growth recorded in 2022. Therefore, the burgeoning pharmaceutical industry is propelling the growth of the NGS-based RNA-sequencing market.

How Is The NGS-Based RNA-Sequencing Market Examined Through Segment Analysis?

The ngs-based rna-sequencing market covered in this report is segmented –

1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management

2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing

3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly

4) By End User: Research & Academia, Pharmaceutical & Biotechnology Companies, Other End Users

Subsegments:

1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents

2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables

3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services

4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms

Which Trends Are Supporting The Evolution Of The NGS-Based RNA-Sequencing Market?

Companies prominent in the NGS-based RNA-sequencing market are prioritizing the creation of novel offerings, specifically sophisticated small RNA-seq kits, to optimize workflows and enhance the precision and effectiveness of RNA expression analysis. These advanced kits represent next-generation library preparation instruments crafted for precise capture and sequencing of small RNAs, enabling researchers to shorten workflow durations, mitigate artifacts like adapter dimers, and attain more accurate and consistent expression profiling. As an example, in October 2025, the Austrian biotechnology firm Lexogen introduced its miRVEL Profiling Small RNA-Seq Library Prep Kit, which aims to simplify and refine small RNA research processes. This groundbreaking kit offers a quicker and more dependable workflow, allowing the preparation of libraries ready for sequencing in less than seven hours, requiring minimal manual input. Key features include cutting-edge adapter blocking technology to inhibit adapter dimer formation, guaranteeing consistent outcomes across different input quantities, and integrated 8 nt unique dual indices (UDIs) for precise multiplexing and read assignment. The miRVEL Profiling Kit accommodates diverse applications, such as RNA interference investigations, host-defense mechanism examinations, and small RNA research in plant or agricultural contexts. Furthermore, it is compatible with Lexogen’s SPLIT RNA extraction kits and TraPR small RNA enrichment system, thereby offering a comprehensive, end-to-end solution for small RNA analysis.

Which Companies Are Influencing The NGS-Based RNA-Sequencing Market?

Major companies operating in the ngs-based rna-sequencing market are Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Genohub LLC, BaseClear B.V., Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

Access The Complete NGS-Based RNA-Sequencing Market Report:

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Which Region Stands As The Largest Contributor To The NGS-Based RNA-Sequencing Market?

North America was the largest region in the NGS-based RNA sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a NGS-Based RNA-Sequencing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Browse Through More Reports Similar to the Global NGS-Based RNA-Sequencing Market 2026, By The Business Research Company

Clinical Next Generation Sequencing Ngs Data Analysis Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-next-generation-sequencing-ngs-data-analysis-global-market-report

Rna Sequencing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

Next Generation Sequencing Market 2026

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

By 2030, How Much Growth In Market Size Is Expected For The NGS-Based RNA-Sequencing Market?

The ngs-based rna-sequencing market size has experienced significant expansion in recent years. It is anticipated to increase from $4.2 billion in 2025 to $5.27 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 25.3%. The growth observed in prior periods can be attributed to the broadening of genomic research initiatives, a reduction in the cost of sequencing technologies, expanded utilization of rna-seq in academic research, the accessibility of advanced sequencing platforms, and the development of bioinformatics capabilities.

The ngs-based rna-sequencing market is projected for rapid expansion in the coming years. This market is anticipated to reach a valuation of $12.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 24.7%. Drivers for this growth during the projected timeframe include the expanding use of RNA sequencing in clinical diagnostics, increased funding for precision medicine, the broadening scope of pharmaceutical research applications, a rising need for integrated data analysis tools, and a heightened emphasis on multi-omics research. Key trends expected within this period involve the greater uptake of high-throughput RNA sequencing platforms, increasing interest in single-cell RNA sequencing, wider utilization of cloud-based bioinformatics analysis, the integration of transcriptomics into precision medicine, and a stronger focus on data precision and scalability.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp

What Key Growth Drivers Are Influencing The NGS-Based RNA-Sequencing Market?

The expanding pharmaceutical sector is anticipated to boost the future growth of the NGS-based RNA-sequencing market. This industry encompasses the discovery, development, and production of drugs and medicines by both governmental and private entities. The pharmaceutical industry utilizes NGS-based RNA-sequencing for comprehensive analysis of gene expression, identification of potential drug targets, assessment of drug responses, and understanding disease mechanisms, thereby facilitating drug discovery and development through a deeper understanding of molecular processes. For instance, in June 2025, according to the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, prescription drug outlays increased by 11.4% in 2023, reaching $449.7 billion, which was an acceleration from the 7.8% growth recorded in 2022. Therefore, the burgeoning pharmaceutical industry is propelling the growth of the NGS-based RNA-sequencing market.

How Is The NGS-Based RNA-Sequencing Market Examined Through Segment Analysis?

The ngs-based rna-sequencing market covered in this report is segmented –

1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management

2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing

3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly

4) By End User: Research & Academia, Pharmaceutical & Biotechnology Companies, Other End Users

Subsegments:

1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents

2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables

3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services

4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms

Which Trends Are Supporting The Evolution Of The NGS-Based RNA-Sequencing Market?

Companies prominent in the NGS-based RNA-sequencing market are prioritizing the creation of novel offerings, specifically sophisticated small RNA-seq kits, to optimize workflows and enhance the precision and effectiveness of RNA expression analysis. These advanced kits represent next-generation library preparation instruments crafted for precise capture and sequencing of small RNAs, enabling researchers to shorten workflow durations, mitigate artifacts like adapter dimers, and attain more accurate and consistent expression profiling. As an example, in October 2025, the Austrian biotechnology firm Lexogen introduced its miRVEL Profiling Small RNA-Seq Library Prep Kit, which aims to simplify and refine small RNA research processes. This groundbreaking kit offers a quicker and more dependable workflow, allowing the preparation of libraries ready for sequencing in less than seven hours, requiring minimal manual input. Key features include cutting-edge adapter blocking technology to inhibit adapter dimer formation, guaranteeing consistent outcomes across different input quantities, and integrated 8 nt unique dual indices (UDIs) for precise multiplexing and read assignment. The miRVEL Profiling Kit accommodates diverse applications, such as RNA interference investigations, host-defense mechanism examinations, and small RNA research in plant or agricultural contexts. Furthermore, it is compatible with Lexogen’s SPLIT RNA extraction kits and TraPR small RNA enrichment system, thereby offering a comprehensive, end-to-end solution for small RNA analysis.

Which Companies Are Influencing The NGS-Based RNA-Sequencing Market?

Major companies operating in the ngs-based rna-sequencing market are Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Genohub LLC, BaseClear B.V., Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

Access The Complete NGS-Based RNA-Sequencing Market Report:

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Which Region Stands As The Largest Contributor To The NGS-Based RNA-Sequencing Market?

North America was the largest region in the NGS-based RNA sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a NGS-Based RNA-Sequencing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Browse Through More Reports Similar to the Global NGS-Based RNA-Sequencing Market 2026, By The Business Research Company

Clinical Next Generation Sequencing Ngs Data Analysis Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-next-generation-sequencing-ngs-data-analysis-global-market-report

Rna Sequencing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

Next Generation Sequencing Market 2026

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The NGS-Based RNA-Sequencing Market In 2026 And 2030? _x000D_

The ngs-based rna-sequencing market has experienced substantial growth in recent years. This market is expected to expand from $4.2 billion in 2025 to $5.27 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 25.3%. The drivers behind this historical growth encompass the expansion of genomic research initiatives, the decreasing cost of sequencing technologies, increased utilization of rna-seq in academic research, the availability of advanced sequencing platforms, and the advancement of bioinformatics capabilities._x000D_

_x000D_

The ngs-based rna-sequencing market is projected to experience rapid expansion over the coming years. This market is set to reach a valuation of $12.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 24.7%. The anticipated growth during this period stems from the greater uptake of rna sequencing in clinical diagnostics, escalating investments in precision medicine, the broadening scope of pharmaceutical research applications, a rising need for integrated data analysis solutions, and a heightened emphasis on multi-omics research. Significant developments expected during the forecast timeframe encompass the wider adoption of high-throughput rna sequencing platforms, an increasing demand for single-cell rna sequencing, the expanding utilization of cloud-based bioinformatics analysis, the broader application of transcriptomics within precision medicine, and an intensified focus on both data accuracy and scalability._x000D_

_x000D_

#Access Your Free Sample Report For In-Depth Market Analysis:#_x000D_

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report_x000D_

_x000D_

What Factors Are Contributing To The Growth Of The NGS-Based RNA-Sequencing Market?_x000D_

The expanding pharmaceutical sector is projected to drive the future development of the NGS-based RNA-sequencing market. This industry segment encompasses the discovery, advancement, and manufacturing of medications and drugs by governmental as well as private organizations. NGS-based RNA-sequencing is employed by the pharmaceutical industry for a thorough analysis of gene expression, pinpointing potential drug targets, evaluating drug reactions, and comprehending disease mechanisms, thereby aiding drug discovery and development through enhanced insight into molecular processes. As an illustration, in June 2025, data from the Centers for Medicare & Medicaid Services (CMS), a federal agency located in the US, indicated that prescription drug expenditures increased by 11.4% in 2023, reaching $449.7 billion, which was an acceleration from the 7.8% growth recorded in 2022. Consequently, the expanding pharmaceutical industry is fueling the growth of the NGS-based RNA-sequencing market._x000D_

_x000D_

Which Segments Define The NGS-Based RNA-Sequencing Market Segment Structure?_x000D_

The ngs-based rna-sequencing market covered in this report is segmented – _x000D_

_x000D_

1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management_x000D_

2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing_x000D_

3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly_x000D_

4) By End User: Research & Academia, Pharmaceutical & Biotechnology Companies, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents_x000D_

2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables_x000D_

3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services_x000D_

4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms_x000D_

_x000D_

What Trends Are Shaping The Future Of The NGS-Based RNA-Sequencing Market?_x000D_

Leading companies within the NGS-based RNA-sequencing market are concentrating on creating novel products, such as sophisticated small RNA-seq kits, to enhance workflow efficiency and boost the precision and effectiveness of RNA expression analysis. These advanced kits represent next-generation library preparation tools designed for the highly precise capture and sequencing of small RNAs, enabling researchers to shorten workflow durations, reduce artifacts like adapter dimers, and obtain more accurate and consistent expression profiles. For example, in October 2025, the Austria-based biotechnology firm Lexogen introduced its miRVEL Profiling Small RNA-Seq Library Prep Kit, crafted to streamline and perfect small RNA research workflows. This innovative kit provides a quicker and more dependable process, allowing for the preparation of ready-to-sequence libraries in under seven hours with minimal manual effort. Key features include advanced adapter blocking technology to stop adapter dimer formation, consistent results across different input quantities, and integrated 8 nt unique dual indices (UDIs) for precise multiplexing and read assignment. The miRVEL Profiling Kit supports diverse applications, including RNA interference studies, investigations into host-defense mechanisms, and small RNA research in plants or agriculture. Furthermore, it is compatible with Lexogen’s SPLIT RNA extraction kits and TraPR small RNA enrichment system, thus offering a complete, integrated solution for small RNA analysis._x000D_

_x000D_

Who Are The Established Players Within The NGS-Based RNA-Sequencing Market?_x000D_

Major companies operating in the ngs-based rna-sequencing market are Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Genohub LLC, BaseClear B.V., Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd. _x000D_

_x000D_

#Get The Full NGS-Based RNA-Sequencing Market Report:#_x000D_

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report_x000D_

_x000D_

Where Is The NGS-Based RNA-Sequencing Market Primarily Concentrated By Region?_x000D_

North America was the largest region in the NGS-based RNA sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request A Customized NGS-Based RNA-Sequencing Market Report For Competitive Insights:#_x000D_

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report_x000D_

_x000D_

#Browse Through More Reports Similar to the Global NGS-Based RNA-Sequencing Market 2026, By The Business Research Company#_x000D_

_x000D_

Clinical Next Generation Sequencing Ngs Data Analysis Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/clinical-next-generation-sequencing-ngs-data-analysis-global-market-report_x000D_

_x000D_

Rna Sequencing Services Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report_x000D_

_x000D_

Next Generation Sequencing Market 2026_x000D_

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market_x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The NGS-Based RNA-Sequencing Market In 2026 And 2030? _x000D_

The ngs-based rna-sequencing market has experienced substantial growth in recent years. This market is expected to expand from $4.2 billion in 2025 to $5.27 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 25.3%. The drivers behind this historical growth encompass the expansion of genomic research initiatives, the decreasing cost of sequencing technologies, increased utilization of rna-seq in academic research, the availability of advanced sequencing platforms, and the advancement of bioinformatics capabilities._x000D_

_x000D_

The ngs-based rna-sequencing market is projected to experience rapid expansion over the coming years. This market is set to reach a valuation of $12.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 24.7%. The anticipated growth during this period stems from the greater uptake of rna sequencing in clinical diagnostics, escalating investments in precision medicine, the broadening scope of pharmaceutical research applications, a rising need for integrated data analysis solutions, and a heightened emphasis on multi-omics research. Significant developments expected during the forecast timeframe encompass the wider adoption of high-throughput rna sequencing platforms, an increasing demand for single-cell rna sequencing, the expanding utilization of cloud-based bioinformatics analysis, the broader application of transcriptomics within precision medicine, and an intensified focus on both data accuracy and scalability._x000D_

_x000D_

#Access Your Free Sample Report For In-Depth Market Analysis:#_x000D_

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report_x000D_

_x000D_

What Factors Are Contributing To The Growth Of The NGS-Based RNA-Sequencing Market?_x000D_

The expanding pharmaceutical sector is projected to drive the future development of the NGS-based RNA-sequencing market. This industry segment encompasses the discovery, advancement, and manufacturing of medications and drugs by governmental as well as private organizations. NGS-based RNA-sequencing is employed by the pharmaceutical industry for a thorough analysis of gene expression, pinpointing potential drug targets, evaluating drug reactions, and comprehending disease mechanisms, thereby aiding drug discovery and development through enhanced insight into molecular processes. As an illustration, in June 2025, data from the Centers for Medicare & Medicaid Services (CMS), a federal agency located in the US, indicated that prescription drug expenditures increased by 11.4% in 2023, reaching $449.7 billion, which was an acceleration from the 7.8% growth recorded in 2022. Consequently, the expanding pharmaceutical industry is fueling the growth of the NGS-based RNA-sequencing market._x000D_

_x000D_

Which Segments Define The NGS-Based RNA-Sequencing Market Segment Structure?_x000D_

The ngs-based rna-sequencing market covered in this report is segmented – _x000D_

_x000D_

1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management_x000D_

2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing_x000D_

3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly_x000D_

4) By End User: Research & Academia, Pharmaceutical & Biotechnology Companies, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents_x000D_

2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables_x000D_

3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services_x000D_

4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms_x000D_

_x000D_

What Trends Are Shaping The Future Of The NGS-Based RNA-Sequencing Market?_x000D_

Leading companies within the NGS-based RNA-sequencing market are concentrating on creating novel products, such as sophisticated small RNA-seq kits, to enhance workflow efficiency and boost the precision and effectiveness of RNA expression analysis. These advanced kits represent next-generation library preparation tools designed for the highly precise capture and sequencing of small RNAs, enabling researchers to shorten workflow durations, reduce artifacts like adapter dimers, and obtain more accurate and consistent expression profiles. For example, in October 2025, the Austria-based biotechnology firm Lexogen introduced its miRVEL Profiling Small RNA-Seq Library Prep Kit, crafted to streamline and perfect small RNA research workflows. This innovative kit provides a quicker and more dependable process, allowing for the preparation of ready-to-sequence libraries in under seven hours with minimal manual effort. Key features include advanced adapter blocking technology to stop adapter dimer formation, consistent results across different input quantities, and integrated 8 nt unique dual indices (UDIs) for precise multiplexing and read assignment. The miRVEL Profiling Kit supports diverse applications, including RNA interference studies, investigations into host-defense mechanisms, and small RNA research in plants or agriculture. Furthermore, it is compatible with Lexogen’s SPLIT RNA extraction kits and TraPR small RNA enrichment system, thus offering a complete, integrated solution for small RNA analysis._x000D_

_x000D_

Who Are The Established Players Within The NGS-Based RNA-Sequencing Market?_x000D_

Major companies operating in the ngs-based rna-sequencing market are Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Genohub LLC, BaseClear B.V., Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd. _x000D_

_x000D_

#Get The Full NGS-Based RNA-Sequencing Market Report:#_x000D_

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report_x000D_

_x000D_

Where Is The NGS-Based RNA-Sequencing Market Primarily Concentrated By Region?_x000D_

North America was the largest region in the NGS-based RNA sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request A Customized NGS-Based RNA-Sequencing Market Report For Competitive Insights:#_x000D_

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report_x000D_

_x000D_

#Browse Through More Reports Similar to the Global NGS-Based RNA-Sequencing Market 2026, By The Business Research Company#_x000D_

_x000D_

Clinical Next Generation Sequencing Ngs Data Analysis Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/clinical-next-generation-sequencing-ngs-data-analysis-global-market-report_x000D_

_x000D_

Rna Sequencing Services Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report_x000D_

_x000D_

Next Generation Sequencing Market 2026_x000D_

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market_x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The NGS-Based RNA-Sequencing Market By 2030 Starting From Its 2026 Size?

The ngs-based rna-sequencing market’s scale has expanded rapidly in recent times. It will grow from $4.2 billion in 2025 to $5.27 billion in 2026 at a compound annual growth rate (CAGR) of 25.3%. Historically, this growth has stemmed from factors such as the broadening of genomic research initiatives, a decrease in the cost of sequencing technologies, greater application of rna-seq in academic studies, the advent of sophisticated sequencing platforms, and advancements in bioinformatics capabilities.

The ngs-based rna-sequencing market is projected to experience substantial expansion over the coming years. Its valuation is forecast to reach $12.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 24.7%. This expansion during the projection period stems from factors such as the greater acceptance of RNA sequencing in clinical diagnostics, increased funding in precision medicine, broader applications in pharmaceutical research, the rising need for integrated data analysis solutions, and a heightened emphasis on multi-omics research. Key developments anticipated over the forecast period involve the wider adoption of high-throughput RNA sequencing platforms, a surge in demand for single-cell RNA sequencing, the increasing utilization of cloud-based bioinformatics analysis, the broadening scope of transcriptomics within precision medicine, and a stronger focus on data precision and scalability.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp

What Drivers Are Shaping The Future Growth Of The NGS-Based RNA-Sequencing Market?

The expanding pharmaceutical sector is anticipated to propel the advancement of the NGS-based RNA-sequencing market moving forward. This industry encompasses the discovery, development, and production of medicines and drugs by both governmental and private entities. The pharmaceutical industry utilizes NGS-based RNA-sequencing to thoroughly analyze gene expression, pinpoint potential drug targets, assess drug responses, and understand disease mechanisms, thereby facilitating drug discovery and development with a deeper understanding of molecular processes. For instance, in June 2025, according to the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, spending on prescription drugs climbed 11.4% in 2023 to $449.7 billion, an acceleration from the 7.8% growth seen in 2022. Therefore, the expanding pharmaceutical industry is fueling the growth of the NGS-based RNA-sequencing market.

Which Segment Categories Define The NGS-Based RNA-Sequencing Market?

The ngs-based rna-sequencing market covered in this report is segmented –

1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management

2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing

3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly

4) By End User: Research & Academia, Pharmaceutical & Biotechnology Companies, Other End Users

Subsegments:

1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents

2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables

3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services

4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms

What Major Market Trends Are Driving Changes In The NGS-Based RNA-Sequencing Market?

Leading entities within the NGS-based RNA-sequencing market are directing their efforts toward creating inventive products, such as sophisticated small RNA-seq kits, to optimize workflows and enhance the precision and effectiveness of RNA expression analysis. These advanced small RNA-seq kits represent cutting-edge library preparation tools specifically designed to capture and sequence small RNAs with high accuracy, assisting researchers in shortening workflow duration, minimizing extraneous elements like adapter dimers, and achieving more precise and consistent expression profiling. As an illustration, in October 2025, Lexogen, an Austria-based biotechnology company, introduced the miRVEL Profiling Small RNA-Seq Library Prep Kit, which aims to simplify and refine small RNA research processes. This innovative kit provides a quicker and more dependable workflow, enabling the preparation of sequencing-ready libraries in less than seven hours with minimal manual intervention. It incorporates advanced adapter blocking technology to inhibit adapter dimer formation, ensures consistent outcomes across different input quantities, and integrates 8 nt unique dual indices (UDIs) for precise multiplexing and read allocation. The miRVEL Profiling Kit supports a wide array of uses, including RNA interference investigations, studies of host-defense mechanisms, and small RNA research in plant or agricultural contexts. Furthermore, it is compatible with Lexogen’s SPLIT RNA extraction kits and TraPR small RNA enrichment system, offering a comprehensive, complete solution for small RNA analysis.

Who Are The Top Companies Competing In The NGS-Based RNA-Sequencing Market?

Major companies operating in the ngs-based rna-sequencing market are Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Genohub LLC, BaseClear B.V., Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

Read the full ngs-based rna-sequencing market report here:

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Which Geographic Regions Are Influencing Demand In The NGS-Based RNA-Sequencing Market?

North America was the largest region in the NGS-based RNA sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored NGS-Based RNA-Sequencing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7416&type=smp

Browse Through More Reports Similar to the Global NGS-Based RNA-Sequencing Market 2026, By The Business Research Company

Clinical Next Generation Sequencing Ngs Data Analysis Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-next-generation-sequencing-ngs-data-analysis-global-market-report

Rna Sequencing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

Next Generation Sequencing Market 2026

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

How much is the NGS-Based RNA-Sequencing Market valued at in 2026, and what valuation is forecast for 2030?

The ngs-based rna-sequencing market has seen remarkable growth over the past few years. It is anticipated to increase from $4.2 billion in 2025 to $5.27 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 25.3%. This historical growth stemmed from factors such as the broadening of genomic research initiatives, the falling costs of sequencing technologies, increased adoption of rna-seq in academic research, the availability of advanced sequencing platforms, and the development of bioinformatics capabilities.

The ngs-based rna-sequencing market is projected to experience substantial expansion over the upcoming years. By 2030, its valuation is anticipated to reach $12.73 billion, demonstrating a compound annual growth rate (CAGR) of 24.7%. This anticipated growth during the forecast timeframe is primarily driven by factors such as the increasing utilization of rna sequencing in clinical diagnostics, growing investments in precision medicine, the broadening scope of pharmaceutical research applications, an escalating need for integrated data analysis solutions, and a heightened emphasis on multi-omics research. Key developments expected within this period involve the increasing uptake of high-throughput rna sequencing platforms, a surging demand for single-cell rna sequencing, the expanding application of cloud-based bioinformatics analysis, the wider integration of transcriptomics in precision medicine, and a stronger emphasis on ensuring data accuracy and scalability.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp

What Drivers Are Influencing The Growth Of The NGS-Based RNA-Sequencing Market?

The expanding pharmaceutical sector is projected to boost the future growth of the NGS-based RNA-sequencing market. This industry encompasses the entire process of finding, developing, and manufacturing pharmaceuticals and medications, undertaken by both public and private organizations. NGS-based RNA-sequencing is employed by the pharmaceutical sector for extensive gene expression analysis, pinpointing possible drug targets, evaluating drug effectiveness, and deciphering disease pathways. This advanced technique enhances drug discovery and development by providing profound insights into molecular functions. As an illustration, data from June 2025 by the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, indicates that spending on prescription drugs increased by 11.4% in 2023, reaching $449.7 billion. This represents an acceleration from the 7.8% growth recorded in 2022. Consequently, the expansion of the pharmaceutical industry is stimulating the growth of the NGS-based RNA-sequencing market.

How Is The NGS-Based RNA-Sequencing Market Organized Into Various Segments?

The ngs-based rna-sequencing market covered in this report is segmented –

1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management

2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing

3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly

4) By End User: Research & Academia, Pharmaceutical & Biotechnology Companies, Other End Users

Subsegments:

1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents

2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables

3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services

4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms

What Industry Trends Are Transforming The NGS-Based RNA-Sequencing Market?

Major companies operating in the NGS-based RNA-sequencing market are prioritizing the development of innovative products, such as advanced small RNA-seq kits, to streamline workflows and improve the accuracy and efficiency of RNA expression analysis. These advanced small RNA-seq kits are cutting-edge library preparation tools engineered to capture and sequence small RNAs with high precision, assisting researchers in reducing workflow duration, minimizing artifacts like adapter dimers, and achieving more accurate and reproducible expression profiling. For instance, in October 2025, Lexogen, an Austria-based biotechnology company, unveiled the miRVEL Profiling Small RNA-Seq Library Prep Kit, specifically designed to simplify and optimize small RNA research workflows. This groundbreaking kit offers a faster and more dependable workflow, allowing for the preparation of ready-to-sequence libraries in under seven hours with minimal hands-on effort. It integrates advanced adapter blocking technology to prevent adapter dimer formation, ensures consistent results across various input amounts, and includes built-in 8 nt unique dual indices (UDIs) for accurate multiplexing and read assignment. The miRVEL Profiling Kit supports a wide array of applications, including RNA interference studies, host-defense mechanism investigations, and plant or agricultural small RNA research. Additionally, it is compatible with Lexogen’s SPLIT RNA extraction kits and TraPR small RNA enrichment system, delivering an integrated, end-to-end solution for small RNA analysis.

Who Are The Prominent Global Companies Shaping The NGS-Based RNA-Sequencing Market Landscape?

Major companies operating in the ngs-based rna-sequencing market are Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Genohub LLC, BaseClear B.V., Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Which Region Is Projected To Lead The NGS-Based RNA-Sequencing Market During The Forecast Period?

North America was the largest region in the NGS-based RNA sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized NGS-Based RNA-Sequencing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7416&type=smp

Browse Through More Reports Similar to the Global NGS-Based RNA-Sequencing Market 2026, By The Business Research Company

Clinical Next Generation Sequencing Ngs Data Analysis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-next-generation-sequencing-ngs-data-analysis-global-market-report

Rna Sequencing Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

Next Generation Sequencing Market 2026

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the ngs-based rna-sequencing market from 2025–2034 with trusted insights from The Business Research Company

How Will The NGS-Based RNA-Sequencing Market Size Evolve Between Now And 2029?

The ngs-based rna-sequencing market has witnessed significant growth over recent years. Its valuation is set to rise from $3.41 billion in 2024 to $4.2 billion in 2025, progressing at a compound annual growth rate (CAGR) of 23.3%. This historical expansion can be attributed to several factors including genomic research initiatives, the reduction in sequencing costs, advancements in drug discovery and development, the development of personalized medicine, and increasing adoption of ngs technology.

The ngs-based rna-sequencing market is projected for rapid expansion over the coming years. This market is anticipated to reach a valuation of $10.26 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 25.0%. Factors driving this growth during the forecast period encompass clinical diagnostics, global collaborations, ethical and regulatory frameworks, agricultural and environmental research, and green genomics. Key trends identified for the same period involve single-cell rna-sequencing (scrna-seq), spatial transcriptomics, epitranscriptomics, multi-omics integration, and sustainable agriculture.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp

Which Key Drivers Are Powering Growth In The NGS-Based RNA-Sequencing Market?

The expansion of precision medicine is a key factor propelling the NGS-based RNA sequencing market. This medical approach assists physicians in crafting bespoke treatment strategies and making therapeutic choices informed by a patient’s genetic disease profile. An increase in precision medicine applications is observed, particularly for managing serious illnesses like cancer. NGS-based RNA sequencing facilitates the pinpointing of disease origins, enabling the prescription of targeted precision medicine for effective treatment. As an illustration, a February 2023 report from the US-based nonprofit Personalized Medicine Coalition (PMC) indicated that personalized medicines constituted 35% of novel NME approvals in 2021. Furthermore, with 12 new approvals in 2022, their share has consistently remained at least a quarter of all new drug approvals for the last eight years, a notable rise from less than 10% a decade prior. Consequently, the rising demand for precision medicines is expected to drive a corresponding increase in the need for NGS-based RNA sequencing.

How Is The Global NGS-Based RNA-Sequencing Market Structured By Key Segments?

The ngs-based rna-sequencingmarket covered in this report is segmented –

1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management

2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing

3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics

4) By End User: Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users

Subsegments:

1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents

2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables

3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services

4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms

What Future-Focused Trends Are Anticipated In The NGS-Based RNA-Sequencing Market?

Strategic collaborations are identified as a prominent trend within the NGS-based RNA sequencing market. Companies are forging partnerships with NGS-based RNA sequencing enterprises to expand into new regions and pool their respective resources. For example, in May 2022, The Biomedical Advanced Research and Development Authority (BARDA), an agency under the U.S. Department of Health and Human Services, established a partnership with various industry and academic organizations. This collaboration is designed to bolster the capacity for prompt responses to public health emergencies and to develop a novel diagnostic capability capable of identifying all recognized and emerging respiratory RNA viruses in one comprehensive test.

Which Companies Hold A Competitive Edge In The NGS-Based RNA-Sequencing Market?

Major companies operating in the ngs-based rna-sequencing market include Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., PerkinElmer Inc., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hamilton Company, Takara Bio Inc., Tecan Trading AG, GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Becton, Dickinson and Company, Genohub LLC, BaseClear B.V., Genewave SAS, Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Which Region Is Expected To Lead The NGS-Based RNA-Sequencing Market In The Next Few Years?

North America was the largest region in the NGS-based RNA sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=7416&type=smp

Browse Through More Reports Similar to the Global NGS-Based RNA-Sequencing Market 2025, By The Business Research Company

Rna Analysis Transcriptomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

Antisense And Rnai Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-global-market-report

Next Generation Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model